Biosyntia

Series-B
biosyntia.com Biotech & Healthcare
Total Funding $12.8M
Latest Round $12.8M Series-B
Last Announced Oct 4, 2022
Investors Undisclosed
Decision Makers 3 Available

About Biosyntia

Produces bio-based vitamin B7 and natural ingredients sustainably.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website biosyntia.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $12,840,000 · Series-B

    biosyntia.com

  2. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Biosyntia.

Funding History

2 Rounds
Series-B equity · Oct 4, 2022
$12,840,000 biosyntia.com
Series-B equity · Jul 6, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts